Biotech | November 26, 2021
Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Owkin builds best-in-class predictive biomedical AI models and robust data sets
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The combined entity will have 12 hospitals with 3,666 beds
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
Subscribe To Our Newsletter & Stay Updated
